During the past decade, Wromedica conducted 25 clinical trials. In the 10-year time frame, 25 clinical trials started and 14 clinical trials were completed, i.e. on average, 56% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 11 clinical trials were completed. i.e. 78.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Wromedica" #1 sponsor was "Janssen Research & Development, LLC" with 8 trials, followed by "Bristol-Myers Squibb" with 3 trials sponsored, "Pfizer" with 3 trials sponsored, "Hoffmann-La Roche" with 2 trials sponsored and "UNION therapeutics" with 2 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Wromedica" #1 collaborator was "Astellas Pharma Inc" with 1 trials as a collaborator, "Duke Clinical Research Institute" with 1 trials as a collaborator, "ICON plc" with 1 trials as a collaborator, "Medidata Solutions" with 1 trials as a collaborator and "Medivation LLC, a wholly owned subsidiary of Pfizer Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Wromedica" are "Psoriasis" (5 trials), "Atopic Dermatitis" (4 trials), "Plaque Psoriasis" (3 trials), "Arthritis, Psoriatic" (2 trials) and "Prostate Cancer" (2 trials). Many other conditions were trialed in "Wromedica" in a lesser frequency.

Most popular intervention types in "Wromedica" are "Drug" (25 trials), "Other" (3 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (18 trials), "Guselkumab" (5 trials), "BMS-986165" (2 trials), "Fenebrutinib" (2 trials) and "JNJ-77242113" (2 trials). Other intervention names were less common.

The vast majority of trials in "Wromedica" are 24 trials for "All" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Wromedica". undefined are not yet recruiting, 4 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 16 completed trials in Wromedica, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Wromedica, 0 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 17 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".